AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Direct Med Supplies joins HIDA, expands national distribution profile
AGP
Direct Med Supplies, a Medford, N.Y.-based medical supply distributor, has joined the Health Industry Distributors Association as it continues serving hospitals, physician practices and surgical centers nationwide.
Gangwon medical firms head to MEDICA 2026 with expanded showcase
AGP
The Wonju Medical Industry Promotion Agency will take 11 Gangwon-based medical companies to MEDICA 2026 in Düsseldorf from Nov. 16-19 to push exports into Europe and global markets.
Stellar Bridge Solutions launches consulting firm for smaller pharma companies
AGP
Stellar Bridge Solutions has launched in Miami to serve small and mid-sized pharma, life sciences, biotech and manufacturing companies that need enterprise-level strategy without the overhead.
Tezspire market seen growing on severe asthma demand
AGP
The Business Research Company says the Tezspire market is expanding as severe asthma cases rise and biologic respiratory treatments gain wider use. The report also points to more clinical trials, stronger research spending and North America’s…
Island Waters Accounting builds AI agents for close and reporting with NumbersGame
AGP
Island Waters Accounting says it cut monthly accounting and reporting work from 10-15 hours to 1-2 hours by connecting Claude to client QuickBooks Online and Xero books through NumbersGame. The San Francisco firm now uses AI for close, reporting…
StrataGraft market projected to grow as burn injuries and regenerative medicine rise
AGP
The Business Research Company says the StrataGraft market is expanding on the back of more burn injuries, stronger demand for advanced wound care, and increasing regenerative medicine research.
Saizen market to grow on rising healthcare spending and personalized medicine
AGP
The Saizen market is set for continued expansion through 2035 as healthcare spending, personalized medicine, and clinical research support broader use of the recombinant growth hormone therapy.
Rixubis market to grow on hemophilia diagnosis and home therapy trends
AGP
The Business Research Company says the global Rixubis market is gaining momentum as hemophilia diagnosis improves, home infusion expands and demand rises for recombinant factor IX therapies.
CNS lymphoma treatment market seen reaching $1.76 billion by 2030
AGP
The central nervous system lymphoma treatment market is projected to rise from $1.27 billion in 2025 to $1.76 billion by 2030, driven by broader use of immunotherapy, targeted treatments and personalized care.
Central lab market seen reaching $4.83 billion by 2030
AGP
The Business Research Company says the central lab market is expanding on stronger clinical research activity, rising trial complexity and growing demand for standardized data.
Catastrophic antiphospholipid syndrome market seen reaching $6.8 billion by 2030
AGP
The catastrophic antiphospholipid syndrome market is projected to expand from $4.6 billion in 2026 to $6.8 billion by 2030, according to a new industry report.
SWGA Homecare wins Georgia provisional home care license
AGP
Albany-based SWGA Homecare received provisional licensure from the Georgia Department of Community Health on Nov. 10, 2026, allowing the company to begin approved non-medical home care services in Southwest Georgia.
Human-relevant drug safety testing market seen nearly doubling by 2033
AGP
Coherent Market Insights says the global market for human-relevant drug safety testing services will rise from $2.18 billion in 2026 to $4.94 billion by 2033. The growth outlook reflects more pharma R&D spending, tighter safety expectations and…
Norditropin market seen growing on healthcare access, trials and demand for long-acting therapies
AGP
The Business Research Company says the global Norditropin market is being shaped by rising diagnosis rates, expanding healthcare infrastructure and more clinical trials.
Biotech and pharma outsourcing market seen reaching $101.56 billion by 2030
AGP
The biotechnology and pharmaceutical services outsourcing market is projected to grow from $77.21 billion in 2026 to $101.56 billion by 2030, driven by rising clinical research, biologics development and demand for specialized external expertise….
Synchrocare opens New Jersey franchise push for medical device distributors
AGP
Synchrocare, LLC is offering franchise opportunities across New Jersey, giving entrepreneurs a way into medical device distribution without a healthcare background.
Biopharma 3PL market seen topping $221 billion by 2030
AGP
The biopharmaceutical third-party logistics market reached $150.5 billion in 2025 and is forecast to hit $221.15 billion by 2030, according to The Business Research Company.
Five modular medical storage makers profile to meet hospital demand in 2026
AGP
A 2026 editorial assessment profiles five manufacturers in modular medical storage as hospitals look for more flexible, infection-safe, and compliant infrastructure.
Imlygic market forecast points to growth in melanoma treatment demand
AGP
The Business Research Company says the Imlygic market is set for growth through 2035 as melanoma diagnoses rise, cancer research funding increases and oncolytic viral therapies gain traction.
Ilumya market growth accelerates as psoriasis treatments expand
AGP
The Business Research Company says the global Ilumya market is gaining momentum, driven by rising psoriasis cases, higher healthcare spending and more investment in clinical trials.
Sign up for:
Medical Industry Today
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.